Ghent, Belgium – June 27th — Clouds of Care welcomes the Novalis Biotech Acceleration Fund, a prominent venture capital firm specializing on Life Sciences innovation, to their investor base in a recent €2 million financing round. This extension round also includes renewed support from existing investors, TCD Capital, FFTF (managed by PMV), and White Fund.
The newly secured funding will strengthen Clouds of Care's position as a pioneer in enabling better clinical development with advanced electrophysiology. In addition to epilepsy-focused clinical development, the company will transform Alzheimer's and Parkinson's disease research and treatment by delivering more precise, data-driven insights into neurodegenerative disease mechanisms.
“We are thrilled to welcome Novalis to our investor community,” said Gregor Strobbe, CEO of Clouds of Care - “Their deep expertise in life sciences and commitment to innovation aligns perfectly with our mission to revolutionize clinical development in neurology.”
Wim Van Criekinge from Novalis commented “We were impressed by the expertise of the Clouds of Care team to support clinical drug development and improve patient monitoring in neurology. Their close collaboration with multiple established pharma and biotech companies demonstrates the pivotal role of their digital technology in derisking clinical trials.” Kjell Mortier further added “The team further impressed us with their capability and professionalism in executing multicenter clinical studies in a global setting”.
This investment will support the expansion of Clouds of Care's electrophysiology platform, enhance their research and development capabilities, and accelerate strategic partnerships aimed at improving outcomes for clinical development in neuroscience.
About Clouds of Care: Clouds of Care NV is an ISO 13485:2016 and ISO 27001:2013-certified MedTech company in Ghent, Belgium, housing CE-marked and FDA-cleared electrophysiology applications for clinicians and tailor-made solutions for clinical trials and research. Through its comprehensive CNS platform and strategic network of partners, Clouds of Care is revolutionizing care for people with Central Nervous System (CNS) disorders.
About Novalis Biotech Acceleration Fund: Novalis is a Venture Capital dedicated to Life Sciences tools, scalable services, and enabling technologies, with a focus on genomics, bioinformatics, diagnostics, and personalized medicine. See more on www.noval.is.
